Strategies and opportunities of micro/nano delivery systems for targeted therapy of ulcerative colitis: Focus on underlying mechanisms and future perspectives
Z Liu, H Liu, J Cheng, H Wang, Y Yang, J Ye… - Chinese Chemical …, 2024 - Elsevier
Ulcerative colitis (UC) is a common progressive inflammatory disease whose incidence has
increased rapidly in recent years, and can develop into colorectal cancer in severe cases …
increased rapidly in recent years, and can develop into colorectal cancer in severe cases …
Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances
S Hu, R Zhao, Y Xu, Z Gu, B Zhu, J Hu - Journal of Materials Chemistry …, 2024 - pubs.rsc.org
Inflammatory bowel disease (IBD) is a chronic and idiopathic condition that results in
inflammation of the gastrointestinal tract, leading to conditions such as ulcerative colitis and …
inflammation of the gastrointestinal tract, leading to conditions such as ulcerative colitis and …
[HTML][HTML] Dual pH and microbial-sensitive galactosylated polymeric nanocargoes for multi-level targeting to combat ulcerative colitis
Ulcerative colitis (UC) is a type of inflammatory bowel disease characterized by
inflammation, ulcers and irritation of the mucosal lining. Oral drug delivery in UC encounters …
inflammation, ulcers and irritation of the mucosal lining. Oral drug delivery in UC encounters …
pH-Sensitive Tacrolimus loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease
Abstract Inflammatory Bowel Disease is the chronic tissue inflammation of the lower part of
the Gastrointestinal tract (GIT). Conventional therapeutic approaches face numerous …
the Gastrointestinal tract (GIT). Conventional therapeutic approaches face numerous …
QbD‐Based Fabrication of Biomimetic Hydroxyapatite Embedded Gelatin Nanoparticles for Localized Drug Delivery against Deteriorated Arthritic Joint Architecture
Biomaterials such as nanohydroxyapatite and gelatin are widely explored to improve
damaged joint architecture associated with rheumatoid arthritis (RA). Besides joint damage …
damaged joint architecture associated with rheumatoid arthritis (RA). Besides joint damage …
Biomaterials for inflammatory bowel disease: treatment, diagnosis and organoids
J Wang, Y Shi, B Mao, B Zhang, J Yang, Z Hu… - Applied Materials …, 2024 - Elsevier
Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease characterized by
intestinal tract inflammation. Although the incidence of IBD is increasing globally, the …
intestinal tract inflammation. Although the incidence of IBD is increasing globally, the …
A Review on Nanosystem-Based Delivery of Tofacitinib for Enhanced Treatment of Autoimmune Diseases and Inflammation
TTL Nguyen, VA Duong - BioNanoScience, 2024 - Springer
Tofacitinib is the first Janus kinase inhibitor approved by the United States Food and Drug
Administration to manage rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and …
Administration to manage rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and …